
    
      A prospective phase I study to evaluate the safety of a single intra-articular injection of
      Ampion™ as a treatment for arthritis of the basal thumb joint.

      Primary Objective is:

      To evaluate the safety of Ampion™ (up to 3 mL) in comparison to saline placebo (up to 3 mL)
      when injected into the basal thumb joint.
    
  